SUBSCRIPTION AGREEMENTSubscription Agreement • January 19th, 2024 • Canopy Growth Corp • Medicinal chemicals & botanical products • Ontario
Contract Type FiledJanuary 19th, 2024 Company Industry JurisdictionWHEREAS the Company has agreed to issue to the Investor [•] units (each, a “Unit”) of the Company at a price of US$4.29 per Unit in connection with an offering for aggregate gross proceeds of US$[•] (the “Offering”), with each Unit consisting of (a) one common share of the Company (each, a “Unit Share”) and (b) in accordance with the terms hereof, (i) one Series A common share purchase warrant (each, a “Series A Warrant”) or (ii) one Series B common share purchase warrant (each, a “Series B Warrant” and, together with the Series A Warrants, the “Warrants”);
SUBSCRIPTION AGREEMENTSubscription Agreement • September 18th, 2023 • Canopy Growth Corp • Medicinal chemicals & botanical products • Ontario
Contract Type FiledSeptember 18th, 2023 Company Industry JurisdictionWHEREAS the Company has agreed to issue to the Investor [__] units (each, a “Unit”) of the Company at a price of US$1.0903 per Unit in connection with an offering for aggregate gross proceeds of US$25 million, and, if exercised within 45 days from the date hereof, in the sole discretion of the Investor, the Company has agreed to issue to the Investor an over-allotment option (the “Over-Allotment Option”) in order to acquire up to [__] Units at a price of US$1.0903 per Unit for additional aggregate gross proceeds, in connection with such offering, of US$25 million (collectively, the “Offering”), with each Unit consisting of one common share of the Company (each, a “Unit Share”) and one common share purchase warrant (each, a “Warrant”);
SUBSCRIPTION AGREEMENTSubscription Agreement • February 21st, 2023 • Canopy Growth Corp • Medicinal chemicals & botanical products • Ontario
Contract Type FiledFebruary 21st, 2023 Company Industry JurisdictionWHEREAS the Company has agreed to issue to the Investor, and the Investor has agreed to purchase from the Company, senior unsecured convertible debentures (the “Convertible Debentures”) in the principal amount of up to US$150,000,000 with an initial US$100,000,000 (the “Initial Subscription Amount”) payable on the Initial Closing Date (as defined below) and an additional US$50,000,000 (the “Second Subscription Amount”) payable on the Second Closing Date (as defined below) in the event certain conditions set forth in Section 2.1(b) are satisfied;
SUBSCRIPTION AGREEMENTSubscription Agreement • February 21st, 2023 • Canopy Growth Corp • Medicinal chemicals & botanical products • Ontario
Contract Type FiledFebruary 21st, 2023 Company Industry JurisdictionWHEREAS the Company has agreed to issue to the Investor, and the Investor has agreed to purchase from the Company, senior unsecured convertible debentures (the “Convertible Debentures”) in the principal amount of up to US$150,000,000 with an initial US$100,000,000 (the “Initial Subscription Amount”) payable on the Initial Closing Date (as defined below) and an additional US$50,000,000 (the “Second Subscription Amount”) payable on the Second Closing Date (as defined below) in the event certain conditions set forth in Section 2.1(b) are satisfied;